Double-blind, vehicle-controlled study to evaluate apoptosis in basal cell carcinoma treated with Aldara (Imiquimod) cream, 5% applied once or twice a day

Trial Profile

Double-blind, vehicle-controlled study to evaluate apoptosis in basal cell carcinoma treated with Aldara (Imiquimod) cream, 5% applied once or twice a day

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2013

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Basal cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jul 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top